Onkos Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 51

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Onkos General Information

Description

Developer of a molecular classifier for precision endocrinology (mir-THYpe) care company intended to provide treatment for thyroid nodules with indeterminate cytology. The company offers a multidisciplinary approach to cancer care, encompassing diagnosis, treatment, thyroid nodules, and support services, enabling customers to access a holistic and patient-centered experience that improves treatment outcomes and quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • R. Florêncio de Abreu, 1945
  • Ribeirao Preto, 14020-028
  • Brazil
+55 (16)
Primary Industry
Laboratory Services (Healthcare)
Corporate Office
  • R. Florêncio de Abreu, 1945
  • Ribeirao Preto, 14020-028
  • Brazil
+55 (16)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Onkos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 16-Mar-2025 Completed Product In Beta Test
1. Accelerator/Incubator 09-Oct-2024 Completed Startup
To view Onkos’s complete valuation and funding history, request access »

Onkos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a molecular classifier for precision endocrinology (mir-THYpe) care company intended to provide treatment f
Laboratory Services (Healthcare)
Ribeirao Preto, Brazil
51 As of 2026

Parsippany, NJ
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Onkos Competitors (3)

One of Onkos’s 3 competitors is Interpace Biosciences, a Private Debt Financed company based in Parsippany, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Interpace Biosciences Private Debt Financed Parsippany, NJ
Veracyte Formerly VC-backed South San Francisco, CA
Sonic Healthcare Corporate Backed or Acquired Sydney, Australia
You’re viewing 3 of 3 competitors. Get the full list »

Onkos Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Onkos Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
La Nave. Accelerator/Incubator
Biominas Brasil Accelerator/Incubator
To view Onkos’s complete investors history, request access »

Onkos FAQs

  • When was Onkos founded?

    Onkos was founded in 2015.

  • Where is Onkos headquartered?

    Onkos is headquartered in Ribeirao Preto, Brazil.

  • What is the size of Onkos?

    Onkos has 51 total employees.

  • What industry is Onkos in?

    Onkos’s primary industry is Laboratory Services (Healthcare).

  • Is Onkos a private or public company?

    Onkos is a Private company.

  • What is Onkos’s current revenue?

    The current revenue for Onkos is .

  • Who are Onkos’s investors?

    La Nave. and Biominas Brasil have invested in Onkos.

  • Who are Onkos’s competitors?

    Interpace Biosciences, Veracyte, and Sonic Healthcare are competitors of Onkos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process